Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. (ALLO) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 279 transactions totaling $179.4M, demonstrating a bearish sentiment with -$113.8M in net insider flow. The most recent transaction on Dec 18, 2025 involved a transaction of 47,700 shares valued at $0.
ALLO Insider Activity Summary
Who Is Buying ALLO Stock?
No significant insider buying has been recorded for ALLO in the recent period.
Who Is Selling ALLO Stock?
No significant insider selling has been recorded for ALLO in the recent period.
Is Allogene Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ALLO is bearish with an Insider Alignment Score of 18/100 and a net flow of -$113.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ALLO Frequently Asked Questions
Understanding ALLO Insider Activity
Insider trading at Allogene Therapeutics, Inc. (ALLO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading ALLO stock, having executed 279 transactions in the past 90 days. The most active insider is James G. Coulter (Executive), who has made 8 transactions totaling $82.5M.
Related Tools
Track Allogene Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ALLO file new Form 4 transactions